From FOIwiki
Jump to navigationJump to search

Decision Summary

  • Case Ref: FS50082569
  • Date: 27 September 2007
  • Public Authority: National Institute for Health and Clinical Excellence
  • Summary: The complainant requested an executable version of the economic model used by NICE in its assessment of Donepezil, Rivastigmine, Galantamine and Memantine, drugs that are used to treat Alzheimer’s Disease. NICE refused to provide the information citing the exemptions in sections 36 and 41 of the Act. The Commissioner has decided that NICE appropriately relied upon section 41 when refusing to supply the information. He has also found that NICE breached section 10 of the Act in initially failing to respond to the request within twenty working days. The Commissioner has not ordered any remedial steps. This decision notice is currently under appeal to the information tribunal.
  • View PDF of Decision Notice: [1]